Mirabilis Medical is the developer of a non-invasive therapeutic ultrasound platform with an initial application to the ablation of uterine fibroids. Symptomatic uterine fibroids affect approximately 25% of all women at some point in their lives, and can cause pain, abnormal bleeding, pregnancy loss, and infertility. The Mirabilis platform uses high resolution ultrasound imaging to localize ablation, and a proprietary ultrasound technology to quickly and non-invasively ablate tissue deep in the body. The company believes that this ablation modality has several other potential clinical applications.
Funding Rounds 1
Mentions in press and media 2